XiaoMi-AI文件搜索系统
World File Search Systemsubsequent
o r i g i n a l r e s a r c h在创伤后2年内随后癫痫患者增加了痴呆症的风险：POP
背景：尽管长期以来已知神经退行性疾病（例如痴呆症）和脑外伤（TBI）之间的关联，但痴呆症和TBI与癫痫之间的关联一直存在争议。AIM：这项基于数据驱动的人群的研究旨在研究2年内TBI之后痴呆症与癫痫之间的关联。方法：该病例对照队列研究是使用纵向健康保险数据库2000（LHID2000）进行的。，我们包括784个人在2001年至2011年间为TBI住院或住院治疗TBI，而有2992例没有癫痫的TBI患者，他们的特征，包括性别，年龄和医疗保健资源使用指数日期。随访每个参与者5年以确定任何痴呆症的发展。使用COX比例危害回归对数据进行了分层和分析。结果：在5年的随访期间，有39例患有癫痫病的TBI患者（5.21％），没有癫痫病的TBI患有55例（1.53％）患有痴呆症。TBI和癫痫病在纠正年龄，性别和合并症后与痴呆症风险> 3.03倍。结论：这些发现表明患有癫痫患者的TBI患者患痴呆症的风险增加。我们的研究建议对患有TBI和癫痫病的人进行更深入的监测。关键词：神经退行性疾病，痴呆，癫痫，创伤性脑损伤，数据驱动，基于人群的研究
鼻咽癌中的toripalimab（loqtorzi）...
•护理标准是1L宝石/顺式；没有1L治疗以外的护理标准； • First ICI approved for NPC (pembro and nivo approved in head & neck squamous cell carcinoma) • NCCN guidelines v4.2024 includes the following as preferred subsequent line option for recurrent, unresectable or metastatic disease (category 2A): Toripalimab (if disease progression on or after platinum-containing therapy) • NCCN Other Recommended Regimens includes subsequent line免疫疗法（2B级）：nivolumab，如果先前治疗，复发性或转移性非转化疾病阶段2（NCI-9742）n = 44; @13 MOS ORR 21％； 1年PFS 19％； 1 yr OS 59% 6 Pembrolizumab if previously treated, PD-L1+ recurrent or metastatic disease or TMB-High (> 10 mut/Mb) KEYNOTE-122 N=233 (pembro vs. chemo) Open-label, Phase 3 trial in PD-L1+ NPC @45 mos ORR 23 vs. 26%; OS 17 vs. 15 mos； [HR 0.90（95％CI 0.67-1.19）; p = 0.2262] 5
Pfizer Pipeline
●本演示文稿包括具有重大风险和不确定性的前瞻性陈述，这些陈述可能导致实际结果与此类陈述所表达或暗示的结果有实质性差异。不能保证临床研究成功的管道产品，这些产品将获得必要的监管批准，或者将其证明是商业上成功的。如果基本假设证明不准确，风险或不确定性实现，则实际结果可能与前瞻性陈述中的结果有重大不同。Additional information regarding these and other factors can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in our subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov和www.pfizer.com。
2022提前四年的容量拍卖（T-4）交付年2026/27
A consolidated version of the detailed Capacity Market Rules is available here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads /attachment_data/file/1098848/capacity-market-rules-informal-consolidated- version-august-2022.pdf with the subsequent amendments at the time of在此处提供写作：https：//www.gov.uk/government/publications/capacity-market-rules。在本报告的背景下，DB在执行2022年提前容量拍卖（T-4）交付年度2026/27（“ 2022 T-4拍卖”）中的行动是“主题问题”，而上述产能市场规则的上述部分则构成了对主题的“标准”。
药理学和治疗补品
Well-Perfused Tissues: Brain, Heart, Kidney, Splanchnic organs >>> Skeletal Muscles Poorly-Perfused Tissues: Fat, Bone and other viscera Example: IV bolus of propofol High blood flow & high lipophilicity Rapid distribution into CNS Anesthesia Hypnosis Subsequent slower distribution to skeletal muscle & adipose tissue 血浆浓度。降低了从中枢神经系统降低梯度意识恢复2.毛细管渗透性（由毛细管结构（即由内皮细胞之间的缝隙连接和药物的化学性质暴露于缝隙的地下膜的一部分）
CERCLA到RCRA站点协会（FOIA 8） 原位生物环境杂志文章：“化石燃料污染土壤的生物修复”
RUN DATE: 01/27/2025 U.S. EPA SUPERFUND PROGRAM Page 10 of 154 DATA REFRESH DATE: 01/27/2025 11:40:53 2 Source: SEMS Superfund Public User Database VERSION: 200 FOIA-008 – CERCLA to RCRA Site Associations This report reflects site information tracked in EPA's Superfund Enterprise Management System (SEMS) and may not reflect subsequent revisions to RCRA处理程序名称和ID号在EPA的RCRAINFO数据库中跟踪。
收件人：-B2U存储解决方案，Inc
❑ Feasible technology option for initial deployment selected, including project plan for subsequent development phases and testing commerciality of carbon removal credit offtake with customers ❑ Initial deployment site has been selected and a CO2 transport and storage strategy available to meet potential deployment plans ❑ DAC hub concept is identified that incorporates technology maturation plans of multiple potential technologies and available CO2 transportation and storage ❑ Credible LCA framework is developed to test net carbon removal最初部署并告知DAC Hub概念❑社区福利计划草案完成。
实施计划，以增加公众对USDA的访问...
As noted in the OSTP memorandum, the USDA implementation plan and the subsequent policy will be consistent with federal statutes and their implementing regulations regarding information management, including: the Paperwork Reduction Act, E-Government Act, Freedom of Information Act, Federal Information Security Management Act, Privacy Act, Health Information Technology for Economic and Clinical Health Act, Information Quality Act, Foundations for Evidence-Based Policymaking Act, Confidential Information Protection and Statistical Efficiency Act, Federal Policy for保护人类臣民，联邦记录法和其他法律以及要求联邦机构保护商业秘密，机密商业信息，可识别个人身份信息以及其他受法律或政策保护的信息的法规或政策。
探索生物多样性金融景观
3。根据《生物多样性公约》秘书处的责任准备了有关本文件附件附件中包含的生物多样性金融景观的报告，以协助咨询委员会的工作。其准备工作是由委员会成员在全球，地区和国家一级的现有机构以及现有工具，资金和框架的现有机构方面的经验和投入的指导，这些机构可能与该框架动员资源有关。The discussions held by the Committee at its first meeting, in Kinshasa, and the feedback received at its subsequent online meetings were also taken into account, as were the submissions on experiences, good practices and lessons learned with the strategy for resource mobilization received by the Secretariat in response to notification No.2023-087。
JC 2024 108关于重大ICT相关事件报告的可行性的报告
4。该报告的结构反映了用于执行此可行性研究的方法。It includes a thorough analysis of the DORA legal basis and the incident reporting flows and roles and responsibilities established therein, comprehensive stock-taking exercises both on existing incident reporting regimes in the financial sector at EU level, as well as different available solutions, the general minimum high level requirements of an incident reporting system, the identification of the three scenarios to be assessed, the assessment based on the elements identified in Article 21(2) and the subsequent cost and收益分析以及总体结论。因此，该报告提供了有关这些要素中每个要素的全面信息，并在技术附件中提供了其他支持信息和分析。